AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.
Financial Statements
- Click here to download Abbvie Inc's Income Statement
- Click here to download Abbvie Inc's Balance Sheet
- Click here to download Abbvie Inc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Richard Gonzalez
Key Statistics
- Stock Price: $147.75
- Dividend Yield: 3.9%
- Market Capitalization: $257,579,185,990
- Shares Outstanding: 1,768,480,508
- Number of Employees: 2,020
- Trailing 12-Month EPS: $7.51
- Trailing 12-Month DPS: $5.63
- Payout Ratio: 75.0%
Important Dates
- Next Earnings Date: 2023-02-09
- Next Ex-Dividend Date: 2023-01-12
Price Trends
- Current Stock Price: $147.75
- 52-week high: $169.46
- 52-week low: $128.17
- 200-day moving average: $146.91
- 50-day moving average: $156.46
Performance
- 1-Month Price Return: -9.0%
- 3-Month Price Return: -0.4%
- 6-Month Price Return: 3.5%
- 1-Year Price Return: 9.6%
- 2-Year Price Return: 54.4%
- 5-Year Price Return: 58.9%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast